This intervention would overcome many of the obstacles that continue to challenge patients as well as health care providers and significantly improve the lives of those affected by psoriatic disease.
This multi-institution, multi-disciplinary, team-based research network will collaborate to address how to overcome the burden of psoriatic disease on patient's lives through prevention of disease.
NPF will invest an estimated $6.5 million in the PPI over the next five years to accomplish these goals. The initiative launched in 2020, and is positioned to accelerate the work toward its prevention aims over the five-year time frame. The first stage of funding aims to:
- Create and support collaborations among clinical researchers.
- Outline a multi-faceted, multi-disciplinary virtual team research approach.
- Explain how the multi-disciplinary team approach will have a high likelihood of leading to an intervention for psoriatic disease, relapse and its related comorbidities.
The initiative was developed in partnership with the PPI Steering Committee, made up of members of the NPF’s scientific advisory committee, medical board, board of directors, bench and translational researchers, clinical advisors and patient constituents.